Exam 3 Flashcards
(290 cards)
Benign Breast Pathologies (4)
- Acute Mastitis
- Duct Ecstasia
- Fibroadenoma
- Fibrocystic Change
Acute Mastitis: Epidemiology
- occurs almost exclusively in lactating women
- usually in first several months post partum
Acute Mastitis: Pathogenesis
- Occurs in presence of milk stasis which happens with obstruction of a milk duct… this leads to engorgement and potentially the release of milk into the surrounding breast tissue which induces an inflammatory response
- may allow for infection (staph aureus or streptococcus)
- can also develop without milk stasis when bacteria enters through cracked/damaged nipples.
Acute Mastitis: Clinical Presentation
- pain/tenderness, swelling, redness, and warmth of breast
- low grade fever and malaise
Acute Mastitis: Treatment
- drainage of milk from the breast
- warm compress, rest, and antibiotics if necessary
Is it safe for the baby to drink the milk of acute mastitis?
- yes, gastric juices of infant’s stomach kill infectious agents
Duct Ecstasia: Pathogenesis
- large ducts near the nipple become dilated (ecstatic)
- at least some cases appear to be related to degenerative changes of the duct wall
Duct Ecstasia: Epidemiology
- usually occurs in older, multiparous women
Duct Ecstasia: Clinical Presentation
- nipple discharge (white), and sometimes nipple retraction
- fibrosis may develop around the dilated ducts and mimic carcinoma
Duct Ecstasia: Microscopic Findings
- chronic inflammation and dilated ducts filled with macrophages and debris
Duct Ecstasia: Treatment
- if no mass legion, no treatment is necessary
- is mass is present, excision may be done to exclude carcinoma.
Fibroadenoma
- Benign tumors of the breast that are composed of proliferating stromal and epithelial cells
Fibroadenoma: Epidemiology
- Usually occur in women in their 20s and 30s
- can be multiple and/or bilateral
- most common benign tumor in the breast
- ~10% of women
Fibroadenoma: Pathogenesis
- thought to occur in response to estrogen stimulation of the tissue
- polyclonal proliferation of cells
Fibroadenoma: Clinical Presentation
- mobile, round mass, ranging from 1cm to 4cm
Fibroadenoma: Microscopic Findings
- well-circumscribed, round legions
Fibroadenoma: Treatment
- some may not need treatment, others are removed
Fibrocystic Change
- umbrella term
- encompasses numerous benign changes in the breast
Fibrocystic Change: Epidemiology
- occurs most commonly in premenopausal women,but can occur in older women as well
Fibrocystic Change: Clinical Presentation
- can mimic clinical signs of BC like mass formation, mammographic calcification, other mammogram abnormalities
Fibrocystic Change: 3 histologic changes
- ranked according to severity
- Non-Proliferative
- Proliferative (ductal hyperplasia) (1.5-2x the risk of BC)
- Atypical Proliferative (4-5x the risk of BC)
Fibrocystic Change: Treatment
- no treatment required, biopsy may be performed to rule out cancer
Breast Cancer risk factors (5)
- Gender (F: 12% lifetime risk, M: 0.11% risk)
- Age (risk increases with age, average age 61)
- Genetic Factors (family history, BRCA1/2) (genetic is 3% of all BC)
- Estrogen Exposure (high levels of estrogen increase risk)
- Radiation Exposure (therapeutic doses)
BC: Incidence and Mortality
- 2nd leading cause of cancer death in US
- incidence rose in early 80s (better screening), has leveled off
- mortality declining since 1990s